{"originalText": "，缘于入院前4个月(2015-09-14)，于我院查肠镜：升结肠肠乳头状管状腺癌II级，遂于3个月前(2015年09月21日)全麻上行腹腔镜上左半结肠根治性切除术，，术中探查见：探查腹腔内无明显出血，无明显腹水，升结肠可见肿瘤，近端几达回盲部，远端近肝曲，明显侵出浆膜层，与周围组织稍明显粘连，未形成梗阻，近端肠管无扩张，周围及肠系膜根部可见数个肿大淋巴结；术后病理(N201503896)，：左半结肠回盲部隆起型管状腺癌II级，伴神经内分泌分化及坏死，侵及浆膜层，脉管内见癌栓，手术标本结肠切端、回肠切端及另送（下切端）、（上切端）均未见癌浸润。找到回肠周淋巴结2个，结肠周淋巴结29个均未见癌转移。术顺，术后分别于2015-10-22、2015-11-13、2015-12-05、2015-12-27行“奥沙利铂D1200MGIVGTT+希罗达D2-141500MGPOBID”方案化疗4次，化疗过程顺利，今为进一步化疗，门诊拟“结肠癌术后”收住入院。自下次出院以来，精神、食欲、睡眠尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 29, "end_pos": 43}, {"end_pos": 81, "label_type": "手术", "overlap": 0, "start_pos": 67}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 165}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 197, "end_pos": 214}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 354}, {"end_pos": 374, "label_type": "药物", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 417, "end_pos": 422}]}
